| 50.69 |  +1.53 / +3.11% |
As of 4:00pm ET | Day’s Change |
| 50.69 |  0.00 / 0.00% |
Volume: 4.2K |
| Benzinga's Volume Movers Feb 26 / Benzinga |
| Previous close | 49.16 |
| Today’s open | 49.22 |
| Day’s range | 48.53 - 51.50 |
| Volume | 1,026,354 |
| Average volume (3 months) | 680,895 |
| Market cap | $1.5B |
| Dividend yield | -- |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | +1.01% |
| Earnings growth (next 5 years) | +35.00% |
| Revenue growth (last year) | +53.83% |
| P/E ratio | 9.4 |
| Price/Sales | 7.68 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| NEOGNeogen Corp | +0.05 | +0.10% |
| GHDXGenomic Health Inc | +0.38 | +1.24% |
| QDELQuidel Corp | +0.14 | +0.54% |
| VIVOMeridian Bioscience ... | +0.06 | +0.30% |
| Next reporting date | April 28, 2015 |
| EPS forecast (this quarter) | $1.00 |
| Annual revenue (last year) | $124.4M |
| Annual profit (last year) | $135.8M |
| Net profit margin | 109.19% |
Sector Health Technology |
Industry Biotechnology |
President, CEO & Executive Director William K. Heiden |
Chief Operating Officer & Executive Vice President Frank E. Thomas |
Corporate headquarters Waltham, Massachusetts |
